Susquehanna International Group’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-19,300
Closed -$191K 14675
2022
Q2
$191K Sell
19,300
-700
-4% -$6.91K ﹤0.01% 10707
2022
Q1
$197K Sell
20,000
-101,100
-83% -$993K ﹤0.01% 11260
2021
Q4
$1.19M Buy
121,100
+1,300
+1% +$12.8K ﹤0.01% 6843
2021
Q3
$1.18M Buy
119,800
+70,000
+141% +$689K ﹤0.01% 7142
2021
Q2
$493K Buy
49,800
+33,500
+206% +$337K ﹤0.01% 9634
2021
Q1
$167K Buy
+16,300
New +$181K ﹤0.01% 11565

Susquehanna International Group's LUXA Position: Q4 2022 in Review

Susquehanna International Group sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 30,172 shares — an estimated $302K sold.

Susquehanna International Group first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $1.43M in Q2 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

  • Susquehanna International Group reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 30,172 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $302K.
  • Susquehanna International Group first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
  • Susquehanna International Group's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $1.43M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.